Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03289949
PHASE1
The Neurobiological Effect of 5-HT2AR Modulation
Sponsor: Gitte Moos Knudsen
View on ClinicalTrials.gov
Summary
The investigators wish to investigate neurobiological effects of serotonin 2A receptor modulation in healthy volunteers, contrasting effects of an agonist (psilocybin) and an antagonist (ketanserin). Magnetic resonance imaging (MRI) and positron emission tomography (PET) will be used as neuroimaging tools.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2017-03-03
Completion Date
2030-06-01
Last Updated
2024-12-16
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Psilocybine
Oral dose of psilocybine.
DRUG
Ketanserin
Oral dose of ketanserin.
Locations (1)
Neurobiology Research Unit, Rigshospitalet
Copenhagen, Denmark